Treatment for Substance Abuse
The Department provides treatment for substance abuse through a community-based provider system that offers detoxification, treatment and recovery support for adolescents and adults affected by substance misuse, abuse or dependence.
- Detoxification Services: Detoxification focuses on the elimination of substance use. Specifically, detoxification services utilize medical and clinical procedures to assist individuals and adults as they withdraw from the physiological and psychological effects of substance abuse. Detoxification may occur in either a residential or outpatient setting, depending on the needs of the individual.
- Treatment Services: Treatment services include a wide array of assessment, counseling, case management, and support provided in residential and non-residential (outpatient) settings. Treatment services are designed to help individuals and their families who have lost their abilities to control the substance use on their own and require formal, structured intervention and support. Services include various levels of residential, outpatient, and recovery support based on the severity of the addiction. Research indicates that persons who successfully complete substance abuse treatment have better post-treatment outcomes related to future abstinence, reduced use, less involvement in the criminal justice system, reduced involvement in the child-protective system, employment, increased earnings, and better health.
- Recovery Support: Recovery Support is offered during and following treatment to further assist individuals in their development of the knowledge and skills necessary to maintain their recovery. These services include transitional housing, life skills training, parenting skills, and peer-based individual and group counseling.
Individuals who pose a significant risk to themselves or others due to substance abuse impairment can be referred for involuntary assessment and stabilization through the Marchman Act
Methadone
If you are looking for methadone medication-assisted treatment for opioid dependence, please use this link to find a list of licensed providers across the state by region. The table includes accepted forms of payment, medications offered, and if the provider treats pregnant women.
State Methadone Office SOTA
Department of Children & Families
Substance Abuse & Mental Health Program Office
2415 North Monroe Street, Suite 400
Tallahassee Florida 32303-4190
(850) 717-4427
Fiscal Year 2022/2023 Methadone Medication-Assisted Treatment (MAT) Needs Assessment (June 30, 2023) (New)
The FY 2022-2023 Methadone MAT Needs Assessment has identified the need for 13 clinics statewide. The majority of the 13 counties with an identified need, are in the process of being filled by awardees from the FY 2018-2019 Methadone MAT Needs Assessment. After accounting for the licensed clinics that have opened or are in the process of opening, the Department will accept applications for a total of 2 new clinics.
|
County |
Number of Clinics |
Note |
|
Highlands |
1 |
This county had an identified need in FY 2018/2019, but it was not filled. |
|
Orange |
1 |
None |
Pursuant to 65D-30.0141, F.A.C., interested parties must submit a letter of intent to apply for licensure to provide medication-assisted treatment for opioid use disorder to the applicable regional licensing office where need has been identified. Letters must include the current fiscal year, the number of awards they are applying for and the counties of interest. Letters of intent must be received by the appropriate regional licensing office via read-receipt email by 5 p.m. EST on July 14, 2023. Letters of Intent for Highlands and/or Orange counties, must be sent to Mary Harmon, Central Region Licensing Supervisor, at@email. Letters of Intent are no longer being accepted in response to this fiscal year’s needs assessment.
By July 25, 2023, the regional licensing office shall notify interested parties who submitted a letter of intent on how to proceed. If the number of letters equals or is less than the determined need for a county, parties shall be awarded the opportunity to pursue licensure by completing a licensing application via PLADS or submitting CF-SA Form 4024, May 2019, to the regional licensing office.
If the number of letters exceeds the determined need for a county, the regional licensing office shall notify interested parties who submitted a letter of intent to then submit a “Methadone Medication-Assisted Treatment (MAT) Application to Proceed to Licensure Application”, form, CF-MH 4041, May 2019. External evaluators will utilize the Methadone Medication Assisted Treatment Application Evaluation document, CF-MH 4040, to score applications. The deadline date for application submission of CF-MH 4041 will be posted on the Department’s website and communicated, via e-mail and certified mail, to those who submitted a letter of intent within the stated timeframe.
The following will be available to stakeholders on the Florida Administrative Register and the Department’s website with links:
- Regional Licensure Office Contact List
- PLADS New Provider Profile to Start an Application
- Substance Abuse Licensure Application Checklist
- Access CF MH 4041 Methadone MAT Application to Proceed to Licensure Application
- Access CF MH 4040 Methadone MAT Application Evaluation
Fiscal Year 2021/2022 Methadone Needs Assessment (June 30, 2022)
The assessment for FY 2021/2022 identified the same number of clinics in the same counties as the FY 2020/2021, 2019/2020 and the 2018/2019 needs assessment. Because no additional need was identified, the Department will not accept letters of interest.
Fiscal Year 2020/2021 Methadone Needs Assessment (June 30, 2021)
The FY 2020/2021 needs assessment has identified the same number of clinics in the same counties as the FY 2019/2020 and the FY 2018/2019 needs assessment. Because no additional need has been identified, the Department will not accept letters of interest as a result of the FY 2020/2021 Methadone Needs Assessment.
Fiscal Year 2019/2020 Methadone Needs Assessment
The FY 2019/2020 needs assessment has identified the same number of clinics in the same counties as the FY 2018/2019 needs assessment. Because no additional need has been identified, the Department will not accept letters of interest as a result of the FY 2019/2020 Methadone Needs Assessment.
Fiscal Year 2018/2019 Methadone Needs Assessment
Below are the award notices for the Fiscal Year 2018/2019 Methadone Needs Assessment. The results for each county evaluation and award are below.
Medication Assisted Treatment
Medication Assisted Treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. Research shows that when treating substance-use disorders, a combination of medication and behavioral therapies is most successful. Medication assisted treatment (MAT) is clinically driven with a focus on individualized patient care.
The opioid brief guide
Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide - highlights information on the use of extended-release injectable naltrexone for the treatment of opioid use disorder along with other MAT options, including assessment and monitoring.
The alcohol brief guide
Medication for the Treatment of Alcohol Use Disorder: A Brief Guide - summarizes information on the four medications approved by the Food and Drug Administration for the treatment of alcohol use disorder and discusses screening and patient assessment, treatment planning and monitoring.
Recovery Residence Administrators and Recovery Residences
Pursuant to section 397.4871, F.S., and section 397.487, F.S., the Department of Children and Families shall approve at least one credentialing entity for the purpose of developing and administering a voluntary certification program for recovery residence administrators and residences. Read more.
Licensure, Regulation, and Accreditation
To review important licensure requirements, checklists, forms, substance abuse accrediting agencies, and credentialing entities for recovery residences, please visit the Licensure and Regulation webpage.